Fibrinolytic system
Fibrinolysis, the breakdown of fibrin polymer, occurs by at least two pathways resulting in the active agents protein C and plasmin. The latter is the better characterised and the term fibrinolysis is commonly taken to mean the plasmin pathway; protein C is discussed in the submenu.
Drugs which affect plasmin production are clinically important: accelerating agents include streptokinase; retarding agents include tranexamic acid.
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.